Zivo Bioscience News and Activities

Zivo Bioscience is a company listed under the stock ticker ZIVO (US).

View the org chart displaying its 7 main executives

Most searched biographies at Zivo Bioscience

• John Payne, Chairman of the Board, President and Chief Executive O...
• Laith Yaldoo, Director
• Alison Cornell, Director

Popular executive movements at Zivo Bioscience

• Harlan Miller, Vice President, Technology and Global Supply, has left the company  (posted on September 24 2025).

Create your alert
to follow the executive moves at Zivo Bioscience.

Zivo Bioscience has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Zivo Bioscience

• ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities :: Zivo Bioscience, Inc. (ZIVO)
• ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza :: Zivo Bioscience, Inc. (ZIVO)
• Press Releases :: Zivo Bioscience, Inc. (ZIVO)
• ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens :: Zivo Bioscience, Inc. (ZIVO)
• Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens :: Zivo Bioscience, Inc. (ZIVO)
• ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study :: Zivo Bioscience, Inc. (ZIVO)
• ZIVO Bioscience Announces Uplisting to OTCQB Market :: Zivo Bioscience, Inc. (ZIVO)
• ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens :: Zivo Bioscience, Inc. (ZIVO)
• ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens :: Zivo Bioscience, Inc. (ZIVO)
• ZIVO Bioscience Announces Reverse Stock Split :: Zivo Bioscience, Inc. (ZIVO)
• View more press releases Close

Social media about Zivo Bioscience

• Zivo Bioscience on Wikipedia, Google News & Yahoo Finance
• Zivo Bioscience on LinkedIn, X (Twitter) & YouTube